Ewelina Pośpiech , Aleksandra Pisarek-Pacek , Kinga Herda , Bożena Wysocka , Aneta Sitek , Magdalena Spólnicka , Wojciech Branicki , Andrzej Ossowski
{"title":"Epigenetic predictor of smoking status in buccal cells","authors":"Ewelina Pośpiech , Aleksandra Pisarek-Pacek , Kinga Herda , Bożena Wysocka , Aneta Sitek , Magdalena Spólnicka , Wojciech Branicki , Andrzej Ossowski","doi":"10.1016/j.taap.2025.117415","DOIUrl":null,"url":null,"abstract":"<div><div>Smoking is the leading cause of accelerated aging and death worldwide. Therefore, identifying and intervening at smoke-responsive DNA methylation markers may be a primary way to reduce mortality risk in the population. Many studies have investigated the association between smoking and DNA methylation in blood samples. Only a few studies have examined saliva and buccal cells in this regard.</div><div>Here, we determined DNA methylation profiles in buccal cells from a total of 280 individuals. Epigenome-wide association analysis (<em>N</em> = 200) uncovered 61 CpG markers, including novel ones, that were significantly associated with smoke exposure in this tissue type. Functional analysis showed that they were overrepresented in the Wnt signaling pathway and fatty acid metabolism. We confirmed that <em>AHRR</em>, a known smoking marker in blood, is also a top locus in buccal cells. However, cg06036945 (<em>p</em> = 1.76 × 10<sup>-10</sup>) and cg04066994 (<em>p</em> = 1.36 × 10<sup>-6</sup>) may be more informative for smoking in buccal epithelium than the commonly reported cg05575921. Moreover, unlike in blood, several other loci with a similar effect size were discovered in our study, including <em>DKK3</em> cg16859537 (<em>p</em> = 3.10 × 10<sup>-10</sup>) and <em>CYP1B1</em> cg02162897 (<em>p</em> = 5.67 × 10<sup>-10</sup>). The <em>CYP1B1</em> and <em>AHRR</em> genes are known to interact through the Ah receptor pathway and play an important role in oxidative stress and mediating toxicity. Finally, logistic regression was employed for variable selection and to derive a novel DNA methylation-based classifier for smoking in buccal cells. Four CpG sites, <em>CYP1B1</em> cg02162897, <em>DKK3</em> cg16859537, <em>AXIN1</em> cg12969952 and <em>PKN1</em> cg12581991 predicted tobacco use with a cross-validated AUC = 0.8, sensitivity of 65.7 % and specificity of 81.5 %. The model was further validated in an independent set of <em>N</em> = 80 samples.</div><div>The identified genes and pathways may serve as targets for intervention or risk stratification in respiratory diseases, while the developed models can also be instrumental in monitoring patient compliance with treatment recommendations and in behavioral profiling within forensic contexts.</div></div>","PeriodicalId":23174,"journal":{"name":"Toxicology and applied pharmacology","volume":"502 ","pages":"Article 117415"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology and applied pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041008X25001917","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Smoking is the leading cause of accelerated aging and death worldwide. Therefore, identifying and intervening at smoke-responsive DNA methylation markers may be a primary way to reduce mortality risk in the population. Many studies have investigated the association between smoking and DNA methylation in blood samples. Only a few studies have examined saliva and buccal cells in this regard.
Here, we determined DNA methylation profiles in buccal cells from a total of 280 individuals. Epigenome-wide association analysis (N = 200) uncovered 61 CpG markers, including novel ones, that were significantly associated with smoke exposure in this tissue type. Functional analysis showed that they were overrepresented in the Wnt signaling pathway and fatty acid metabolism. We confirmed that AHRR, a known smoking marker in blood, is also a top locus in buccal cells. However, cg06036945 (p = 1.76 × 10-10) and cg04066994 (p = 1.36 × 10-6) may be more informative for smoking in buccal epithelium than the commonly reported cg05575921. Moreover, unlike in blood, several other loci with a similar effect size were discovered in our study, including DKK3 cg16859537 (p = 3.10 × 10-10) and CYP1B1 cg02162897 (p = 5.67 × 10-10). The CYP1B1 and AHRR genes are known to interact through the Ah receptor pathway and play an important role in oxidative stress and mediating toxicity. Finally, logistic regression was employed for variable selection and to derive a novel DNA methylation-based classifier for smoking in buccal cells. Four CpG sites, CYP1B1 cg02162897, DKK3 cg16859537, AXIN1 cg12969952 and PKN1 cg12581991 predicted tobacco use with a cross-validated AUC = 0.8, sensitivity of 65.7 % and specificity of 81.5 %. The model was further validated in an independent set of N = 80 samples.
The identified genes and pathways may serve as targets for intervention or risk stratification in respiratory diseases, while the developed models can also be instrumental in monitoring patient compliance with treatment recommendations and in behavioral profiling within forensic contexts.
期刊介绍:
Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.
Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.
Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.